Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,033Revenue $M47.8Net Margin (%)-139.1Z-Score-3.6
Enterprise Value $M998EPS $-1.3Operating Margin %-116.6F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-138.8Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio1.3Cash flow > EarningsY
Price/Sales13.05-y EBITDA Growth Rate %-36.3Current Ratio1.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-59.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M105ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with MACK

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

MACK is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


MACK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PORTER MICHAEL EDirector 2014-11-21Buy11,909$8.877.44 view
Stewart Edward J.SVP & Pres, Healthcare Sol 2014-11-18Sell5,000$8.5511.46 view
PORTER MICHAEL EDirector 2014-11-14Buy5,000$8.2914.96 view
CROCKER GARY LDirector 2014-11-13Buy14,390$8.4712.51 view
PORTER MICHAEL EDirector 2014-11-12Buy40,000$8.3713.86 view
Stewart Edward J.SVP & Pres, Healthcare Sol 2014-10-23Sell3,000$9.055.3 view
Stewart Edward J.SVP & Pres, Healthcare Sol 2014-10-15Sell4,000$819.13 view
Sullivan William A.CFO and Treasurer 2014-09-30Sell105,282$8.6110.69 view
Stewart Edward J.SVP & Pres, Healthcare Sol 2014-09-24Sell12,000$8.2215.94 view
Stewart Edward J.SVP & Pres, Healthcare Sol 2014-08-26Sell24,000$6.8738.72 view

Press Releases about MACK :

    Quarterly/Annual Reports about MACK:

    News about MACK:

    Articles On GuruFocus.com
    No related article found.


    More From Other Websites
    Insider Trading Alert - FCS, GDOT And MACK Traded By Insiders Nov 25 2014
    Merrimack Pharmaceuticals Presents on Multiple Programs at the 26th EORTC-NCI-AACR Symposium on... Nov 21 2014
    Merrimack Pharmaceuticals Presents on Multiple Programs at the 26th EORTC-NCI-AACR Symposium on... Nov 21 2014
    Merrimack Pharmaceuticals' MM-398 Gets Fast Track Status Nov 20 2014
    PharmaEngine Announces the Receipt of US FDA Fast Track Designation for MM-398 in Post-Gemcitabine... Nov 20 2014
    The S&P failed to extend its 4-day winning streak following headlines out of the Fed Nov 19 2014
    MERRIMACK PHARMACEUTICALS INC Financials Nov 19 2014
    Insider Trading Alert - MACK, GWRE And CCOI Traded By Insiders Nov 19 2014
    Merrimack Pharmaceuticals Receives FDA Fast Track Designation for MM-398 in Post-Gemcitabine... Nov 19 2014
    Merrimack Pharmaceuticals Receives FDA Fast Track Designation for MM-398 in Post-Gemcitabine... Nov 19 2014
    'Mad Money' Lightning Round: I'm Buy, Buy, Buying Biogen Nov 18 2014
    MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Nov 17 2014
    Photo Release -- Merrimack Pharmaceuticals Announces the Addition of Vivian S. Lee, Dean of... Nov 17 2014
    Photo Release -- Merrimack Pharmaceuticals Announces the Addition of Vivian S. Lee, Dean of... Nov 17 2014
    Insider Trading Alert - TASR, SAVE And MACK Traded By Insiders Nov 14 2014
    Merrimack Pharmaceuticals to Present Advances on Targeted Cancer Molecules at the 2014... Nov 13 2014
    Merrimack Pharmaceuticals to Present Advances on Targeted Cancer Molecules at the 2014... Nov 13 2014
    Merrimack posts 3Q loss Nov 10 2014
    Merrimack posts 3Q loss Nov 10 2014
    Merrimack Pharmaceuticals Reports Third Quarter 2014 Financial Results Nov 10 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK